Dr. El Zarif is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
New Haven, CT 06510Phone+1 203-688-4242
Education & Training
Lebanese University School of MedicineClass of 2020
Certifications & Licensure
CT State Medical License 2023 - 2025
Publications & Presentations
PubMed
- Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.Tejas Jammihal, Renee Maria Saliby, Chris Labaki, Hanna Soulati, Juan Gallegos
Nature Cancer. 2025-01-09 - 3 citationsFirst-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.Talal El Zarif, Karl Semaan, Wanling Xie, Marc Eid, Martin Zarba
European Urology. 2024-12-01 - Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With ...Anna Patrikidou, Calogero Saieva, Richard Lee-Ying, Pier Vitale Nuzzo, Talal El Zarif
Clinical Genitourinary Cancer. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
